Decline depth
-62.7%
From rolling 252-day high of $25.95, 45d ago.
Past the 40% Red List threshold.
Red List
BIOABioAge Labs, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · small-cap ($477M)
-62.7%
from rolling 252-day high of $25.95 set 2026-07-06 · 45d ago
Current
$9.69
Decline depth
-62.7%
Decline σ
3.9σ
TFC
3/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$BIOA landed on the list 2026-03-14, down 10.2% from its 52-week high that day — now down -62.7%.
That's 50.3 percentage points deeper than the day it joined.
Decline from the 52-week high as it stood on 2026-03-16 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
BIOA qualifies for the Red List on decline depth.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Past the 3/5 Watch threshold.
Decline sigma
3.9σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (15.78% per day).
The structural read
What price action says about BIOA.
BIOA qualifies for the Red List on decline depth — down -62.7% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.
Cross-confirmation: also showing 3/5 bearish time frames.
Earnings on file: 2026-05-08. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about BIOA
What people ask.
Why is BIOA on Broken Stocks?
BIOA qualifies for the Red List on decline depth. It is down -62.7% from its rolling 252-day high of $25.95, set on 2026-07-06 — 45d ago.
Is BIOA a falling knife?
By the most common technical definition — a steep, recent breakdown from a fresh high — yes. BIOA is down -62.7% from its 52-week high of $25.95, set 45d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.
Is BIOA a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is BIOA trading inside its 52-week range?
At $9.69, BIOA sits 24.6% of the way from its 52-week low ($4.38) to its 52-week high ($25.95). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has BIOA been declining?
The current 62.7% decline accrued over 45d, which annualizes to roughly -508.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does BIOA compare to its sector?
There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — BIOA's decline is deeper than the sector median.
Does BIOA's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-08) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.